These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 17418457)

  • 21. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18.
    Liu Q; Shang L; Jin H; Wei F; Zhu XQ; Gao H
    Res Vet Sci; 2010 Aug; 89(1):93-7. PubMed ID: 20132954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis.
    Gatkowska J; Gasior A; Kur J; Dlugonska H
    Exp Parasitol; 2008 Feb; 118(2):266-70. PubMed ID: 17825290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.
    Min J; Qu D; Li C; Song X; Zhao Q; Li XA; Yang Y; Liu Q; He S; Zhou H
    Vaccine; 2012 Aug; 30(38):5631-6. PubMed ID: 22789504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
    Chuang SC; Ko JC; Chen CP; Du JT; Yang CD
    Parasit Vectors; 2013 Feb; 6():34. PubMed ID: 23398973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
    Chen G; Chen H; Guo H; Zheng H
    Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
    Yang X; Huang S; Chen J; Song N; Wang L; Zhang Z; Deng G; Zheng H; Zhu XQ; Lu F
    Vaccine; 2010 Jan; 28(3):737-43. PubMed ID: 19887128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
    Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
    Jongert E; de Craeye S; Dewit J; Huygen K
    Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
    Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
    Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
    Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
    Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.